(Q50959095)

English

Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenesis in high-fat diet-fed APPSWE /PSEN1dE9 mouse model of Alzheimer's disease.

scientific article published on 18 November 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenesis in high-fat diet-fed APPSWE /PSEN1dE9 mouse model of Alzheimer's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

author name string

Ying Tang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Yunhua Peng

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Jing Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Le Shi

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Yongyao Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Jiangang Long

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Jiankang Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

language of work or name

0 references

publication date

18 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

From mice to men: insights into the insulin resistance syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

The LDL receptor

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Cross-talk between liver and intestine in control of cholesterol and energy homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

The role of insulin and glucose in goose primary hepatocyte triglyceride accumulation.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Increased risk of type 2 diabetes in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Metabolic links between diabetes and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Is Alzheimer's disease a systemic disease?

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Role of the liver in the control of carbohydrate and lipid homeostasis

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Plasma aβ: a possible missing link between Alzheimer disease and diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

A meta-analysis of cytokines in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Amyloid-β induces hepatic insulin resistance in vivo via JAK2.

1 reference

https://api.crossref.org/works/10.1111%2FJNC.13437

21 January 2018

Identifiers

10.1111/JNC.13437

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/26578392

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50959095&oldid=941972697"